We are live on
!
Find out more
Aviva Portfolio holdings
AUM
$59.6B
1-Year Est. Return
28.44%
This Fund
S&P 500
This Quarter
Est. Return
+9.14%
1 Year Est. Return
+28.44%
3 Year Est. Return
+95.57%
5 Year Est. Return
+123.24%
10 Year Est. Return
+442.53%
AUM
$22.8B
AUM Growth
+$2.32B
(+11%)
Cap. Flow
-$486M
Cap. Flow
% of AUM
-2.13%
Top 10 Holdings %
Top 10 Hldgs %
22.89%
Holding
1,019
New
29
Increased
317
Reduced
427
Closed
158
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$47M |
| 2 |
Qiagen
QGEN
|
+$31.1M |
| 3 |
Elanco Animal Health
ELAN
|
+$29.5M |
| 4 |
Amazon
AMZN
|
+$27.9M |
| 5 |
Tesla
TSLA
|
+$22.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$138M |
| 2 |
Charter Communications
CHTR
|
+$79.7M |
| 3 |
Comcast
CMCSA
|
+$70.1M |
| 4 |
Stellantis
STLA
|
+$55.4M |
| 5 |
Union Pacific
UNP
|
+$43M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.87% |
| 2 | Financials | 14.25% |
| 3 | Healthcare | 12.4% |
| 4 | Consumer Discretionary | 11.73% |
| 5 | Communication Services | 10.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
876
LeMaitre Vascular
LMAT
$2.37B
| – | – |
-26,012
| Closed | -$1.27M |
|
877
Lindsay Corp
LNN
$1.14B
| – | – |
-7,419
| Closed | -$1.24M |
|
878
Grand Canyon Education
LOPE
$4.22B
| – | – |
-10,962
| Closed | -$1.17M |
|
879
Lattice Semiconductor
LSCC
$16B
| – | – |
-28,630
| Closed | -$1.29M |
|
880
Landstar System
LSTR
$6.03B
| – | – |
-7,313
| Closed | -$1.21M |
|
881
Manhattan Associates
MANH
$12.1B
| – | – |
-10,288
| Closed | -$1.21M |
|
882
Madrigal Pharmaceuticals
MDGL
$12.6B
| – | – |
-10,495
| Closed | -$1.23M |
|
883
Mesa Laboratories
MLAB
$551M
| – | – |
-4,861
| Closed | -$1.18M |
|
884
Maximus
MMS
$3.32B
| – | – |
-13,779
| Closed | -$1.23M |
|
885
Mercury Systems
MRCY
$5.41B
| – | – |
-17,753
| Closed | -$1.25M |
|
886
Mine Safety
MSA
$6.79B
| – | – |
-7,946
| Closed | -$1.19M |
|
887
MaxLinear
MXL
$5.19B
| – | – |
-37,125
| Closed | -$1.26M |
|
888
Neurocrine Biosciences
NBIX
$18.2B
| – | – |
-13,950
| Closed | -$1.36M |
|
889
Nordson
NDSN
$16.4B
| – | – |
-6,162
| Closed | -$1.22M |
|
890
Neogen
NEOG
$2.05B
| – | – |
-27,956
| Closed | -$1.24M |
|
891
NeoGenomics
NEO
$1.99B
| – | – |
-24,960
| Closed | -$1.2M |
|
892
NewMarket
NEU
$7.24B
| – | – |
-3,123
| Closed | -$1.19M |
|
893
NovaGold Resources
NG
$2.54B
| – | – |
-132,779
| Closed | -$1.16M |
|
|
NIU
894
Niu Technologies
NIU
$200M
| – | – |
-63,349
| Closed | -$2.32M |
|
895
New York Times
NYT
$12.6B
| – | – |
-25,277
| Closed | -$1.28M |
|
896
Universal Display
OLED
$3.75B
| – | – |
-5,363
| Closed | -$1.27M |
|
897
Omnicell
OMCL
$1.88B
| – | – |
-8,686
| Closed | -$1.13M |
|
898
Pegasystems
PEGA
$5.09B
| – | – |
-20,972
| Closed | -$1.2M |
|
899
Penumbra
PEN
$12.6B
| – | – |
-4,534
| Closed | -$1.23M |
|
900
Phathom Pharmaceuticals
PHAT
$928M
| – | – |
-29,463
| Closed | -$1.11M |
|
Similar funds
QCM
NAMI
Aviva's Q2 2021 Portfolio in Review
As of Q2 2021, Aviva held 1,019 positions worth $22.8B, up 11% from $20.5B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Aviva's Q2 2021 filing shows 29 new, 317 increased, 427 reduced and 158 closed positions. Its largest new stake was DoorDash: 44,570 shares worth $7.95M. The largest sale was Alibaba, an estimated $138M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.
- Aviva's largest Q2 2021 buy was DoorDash: 44,570 shares worth $7.95M.
- Aviva added most to Meta Platforms (Facebook) in Q2 2021, an estimated $47M increase.
- Aviva's biggest Q2 2021 reduction was Alibaba, cutting an estimated $138M.
- Aviva fully exited Kilroy Realty in Q2 2021, selling an estimated $8.36M.
- Aviva's ten largest holdings make up 23% of its $22.8B portfolio in Q2 2021.
- Aviva opened 29 new positions and closed 158 in Q2 2021.
- Aviva's portfolio value rose 11% quarter-over-quarter to $22.8B.
Based on Aviva's 13F filing for Q2 2021, filed 10 Aug 2021.